✨ Free AI Report
Memorial Sloan Kettering Cancer Center: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Memorial Sloan Kettering Cancer Center
Company Research

Memorial Sloan Kettering Cancer Center: Business Overview, Financials & Competitive Analysis

Memorial Sloan Kettering Cancer Center scores 8/10 on the AskCyborg Cyborg Score (Strong). Elite clinical and research institution executing digital modernization and major campus expansion to maintain leadership in precision oncology and cancer care delivery. MSK is a preeminent NCI-designated Comprehensive Cancer Center with top-tier clinical rankings, leading-edge research capabilities, and strategic investments in digital transformation and infrastructure expansion. The.

What is Memorial Sloan Kettering Cancer Center's industry? Memorial Sloan Kettering Cancer Center (mskcc.org) operates in Oncology Drugs. AskCyborg classifies Memorial Sloan Kettering Cancer Center under Oncology Drugs in its company registry.

Memorial Sloan Kettering Cancer Center (MSK) was one of the first cancer centers to receive the Comprehensive Cancer Center designation from NCI in 1971, with doctors and scientists working together to fulfill the ins...

8/ 10Strong

Cyborg Score thesis

Elite clinical and research institution executing digital modernization and major campus expansion to maintain leadership in...

Read the full analyst-debate transcript →
Industry Oncology Drugs
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 28, 2026
AI-Verified Research
30+ Page Report

Get the Latest Memorial Sloan Kettering Cancer Center Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Memorial Sloan Kettering Cancer Center

AskCyborg analysts argue the bull and bear cases for Memorial Sloan Kettering Cancer Center across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Memorial Sloan Kettering Cancer Center OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Memorial Sloan Kettering Cancer Center Overview

Pro stress-test →

Memorial Sloan Kettering Cancer Center (MSK) was one of the first cancer centers to receive the Comprehensive Cancer Center designation from NCI in 1971, with doctors and scientists working together to fulfill the institution's commitment to patient care, research, and education. The center's high degree of specialization means that MSK's doctors treat hundreds of cancer subtypes.

Strategic Profile

Pro stress-test →

MSK has been recognized as the best cancer center in the Northeast, the number two hospital for cancer care in the nation, and the number one hospital nationally for urology care by U.S. News & World Report. In May 2026, MSK appointed Shakeeb Akhter as Chief Digital Officer to oversee the overall design and execution of MSK's digital strategy. In May 2026, Turner and Consigli Construction were selected to build The Kenneth C. Griffin Pavilion, a state-of-the-art cancer care facility at MSK's main Manhattan campus.

Competitive Landscape

Pro stress-test →

MSK operates in the specialized cancer care and research sector, competing with other NCI-designated Comprehensive Cancer Centers such as MD Anderson Cancer Center (Houston), Dana-Farber Cancer Institute (Boston), and Mayo Clinic (Rochester). MSK ranks second nationally for cancer care and first nationally for urology care, positioning it as a leading specialty center. The institution differentiates through its integrated research-clinical model and precision medicine capabilities.

Industry Context

Memorial Sloan Kettering Cancer Center operates in Oncology Drugs.

Key facts

Founded: 1980 · Headquarters: New York, US · Employees: N/A · Revenue: N/A · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for Memorial Sloan Kettering Cancer Center.

  • MSK has established standards of care and treatment protocols across cancer types and stages, with doctors treating hundreds of cancer subtypes through highly specialized programs.
  • New CDO Shakeeb Akhter brings experience building advanced healthcare digital transformation programs spanning AI, clinical informatics, cybersecurity, and digitally enabled care from Children's Hospital of Philadelphia.
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • May 2026Appointed Shakeeb Akhter as Chief Digital Officer
  • May 2026Selected Turner Construction and Consigli Construction for $2.3 billion Kenneth C. Griffin Pavilion project
  • +2 moreTrack every material event for Memorial Sloan Kettering Cancer Center as it happens. Explore monitoring →
Get alerted when Memorial Sloan Kettering Cancer Center has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

MD Anderson Cancer CenterLeading NCI Comprehensive Cancer Center in Houston specializing in cancer treatment and research→Dana-Farber Cancer InstituteBoston-based NCI Comprehensive Cancer Center focused on cancer research and patient care→Mayo Clinic Cancer CenterIntegrated healthcare system with NCI-designated Comprehensive Cancer Center in Rochester, Minnesota→

Compare Memorial Sloan Kettering Cancer Center with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Memorial Sloan Kettering Cancer Center operates in Oncology Drugs. See how the rest of the sector scores on the Cyborg framework.

Browse Oncology Drugs research →
NEW · MCP server

Ask your AI assistant about Memorial Sloan Kettering Cancer Center

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Memorial Sloan Kettering Cancer Center and its top competitor on Cyborg Score”
“What did Memorial Sloan Kettering Cancer Center do this quarter?”
“Is Memorial Sloan Kettering Cancer Center a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Memorial Sloan Kettering Cancer Center do?+
Memorial Sloan Kettering Cancer Center (MSK) was one of the first cancer centers to receive the Comprehensive Cancer Center designation from NCI in 1971, with doctors and scientists working together to fulfill the ins...
What is Memorial Sloan Kettering Cancer Center's Cyborg Score?+
Memorial Sloan Kettering Cancer Center has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Memorial Sloan Kettering Cancer Center's main competitors?+
Named competitors include MD Anderson Cancer Center, Dana-Farber Cancer Institute, Mayo Clinic Cancer Center. The full competitive landscape is in the AskCyborg report.
How can I get the full Memorial Sloan Kettering Cancer Center research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Memorial Sloan Kettering Cancer Center research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Memorial Sloan Kettering Cancer Center over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.